| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.03 | $40.26 (0%) | 🛒 Add to cart |
| 20 | $3.02 | $80.52 $60.39 (25%) | 🛒 Add to cart |
| 30 | $2.35 | $120.78 $70.46 (42%) | 🛒 Add to cart |
| 60 | $1.34 | $241.57 $80.52 (67%) | 🛒 Add to cart |
| 90 | $1.01 | $362.35 $90.59 (75%) | 🛒 Add to cart |
| 120 | $0.84 | $483.13 $100.65 (79%) | 🛒 Add to cart |
| 180 | $0.75 | $724.70 $135.88 (81%) | 🛒 Add to cart |
| 270 | $0.67 | $1087.04 $181.17 (83%) | 🛒 Add to cart |
| 360 | $0.59
Best per pill | $1449.39 $211.37 (85%) | 🛒 Add to cart |
Similar products
More info:
zyban
Zyban, known generically as bupropion hydrochloride, is a prescription medication primarily indicated as an aid to smoking cessation. It’s classified as an atypical antidepressant and norepinephrine-dopamine reuptake inhibitor (NDRI), distinct from nicotine replacement therapies. What makes Zyban particularly valuable in clinical practice is its dual-action approach - it doesn’t just replace nicotine but actually addresses the neurochemical drivers of addiction. I remember when we first started using Zyban in our smoking cessation clinic back in the late 90s - we were frankly skeptical.
bupropion
Bupropion is an atypical antidepressant belonging to the norepinephrine-dopamine reuptake inhibitor (NDRI) class, distinct from the more common SSRIs. Initially approved for depression in 1985, it’s become a cornerstone treatment for major depressive disorder and smoking cessation, with off-label uses expanding significantly. What makes bupropion particularly valuable is its unique pharmacological profile—it doesn’t typically cause sexual dysfunction or weight gain, side effects that often complicate treatment with other antidepressants. In my practice, I’ve seen it literally give patients their lives back when other medications failed, especially those who couldn’t tolerate SSRI side effects.
wellbutrin
Wellbutrin, known generically as bupropion, is an atypical antidepressant and smoking cessation aid that functions primarily as a norepinephrine-dopamine reuptake inhibitor (NDRI). Unlike many antidepressants that target serotonin, Wellbutrin’s unique mechanism has made it a valuable tool for treating major depressive disorder, seasonal affective disorder, and aiding smoking cessation, particularly when patients experience undesirable side effects like weight gain or sexual dysfunction with other medications. 1. Introduction: What is Wellbutrin? Its Role in Modern Medicine Wellbutrin (bupropion hydrochloride) represents a distinct class of antidepressant medication that differs significantly from selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs).
wellbutrin sr
Bupropion hydrochloride, the active ingredient in Wellbutrin SR, represents one of the more interesting second-generation antidepressants in our arsenal. Unlike the SSRIs that dominate first-line treatment, it works primarily as a norepinephrine-dopamine reuptake inhibitor, which gives it a completely different side effect and efficacy profile. I remember when it first came to market - we were all skeptical about another “miracle drug,” but over two decades of clinical use have revealed some remarkable applications beyond its original indication.
a ret gel
A topical retinoid gel containing 0.025% tretinoin in a stabilized hydrogel base, designed for gradual release and reduced irritation compared to traditional formulations. The formulation includes niacinamide 4% to enhance barrier function and hyaluronic acid 0.5% for sustained hydration throughout the treatment period. Key Components and Bioavailability of Ret Gel The ret gel formulation represents a significant advancement in topical retinoid delivery systems. The primary active ingredient, tretinoin at 0.025% concentration, is stabilized through microencapsulation technology that protects the molecule from oxidative degradation while allowing controlled release.
Abana: Comprehensive Cardiovascular Support Through Multi-Targeted Action - Evidence-Based Review
Product Description Abana represents one of those formulations that initially puzzled me when I first encountered it in integrative cardiology practice. It’s not your standard single-herb supplement but rather a sophisticated polyherbal formulation with roots in Ayurvedic medicine, specifically developed for cardiovascular support. The product typically comes in tablet form and contains a carefully balanced combination of herbs including Terminalia arjuna, Withania somnifera, and Ocimum sanctum among others. What struck me early on was how this formulation approached cardiovascular health from multiple angles simultaneously - something we rarely see in conventional single-agent therapies.
abhigra
Let me tell you about this supplement that’s been creating quite a stir in my practice lately. Abhigra isn’t your typical herbal supplement - it’s a standardized extract from the roots of Withania somnifera, but processed using a proprietary cold-extraction method that preserves the delicate withanolides that give this plant its therapeutic punch. The manufacturer claims this method yields a 15% withanolide concentration, which is substantially higher than most commercial ashwagandha products.
abilify
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in the atypical antipsychotic class with its unique pharmacodynamic profile. Unlike earlier antipsychotics that primarily functioned as dopamine antagonists, aripiprazole’s mechanism as a partial dopamine agonist created what we initially called a “dopamine stabilizer” - though that term has fallen out of favor in academic circles now. The drug’s development stemmed from Otsuka Pharmaceutical’s research into creating an agent that could modulate dopamine transmission without completely blocking it, addressing both positive and negative symptoms while minimizing extrapyramidal side effects.
Acamprol: Effective Craving Reduction and Neuroregulation in Alcohol Dependence - Evidence-Based Review
In my early neurology practice, we kept hitting a wall with certain patients—those with moderate alcohol dependence who’d failed standard therapies or couldn’t tolerate naltrexone due to hepatic issues. We’d cycle them through counseling, SSRIs, even off-label topiramate, but the relapse rates remained stubbornly high. That’s when our head of research, Dr. Aris Thorne, came back from a European conference buzzing about this compound called acamprol. Honestly, most of us were skeptical.